- Ünal Ç,et al. Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group. Oncologist. 2023 Sep 7:oyad257. doi: 10.1093/oncolo/oyad257. Epub ahead of print. PMID: 37676712. - Ünal, Ç., Özmen, T., İlgün, A. S., Ordu, Ç., Özkurt, E., Ak, N., ... & Özmen, V. (2023). MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification. Breast Cancer: Targets and Therapy, 659-669. - Ünal, Ç., Tunçer, G., Çopur, B., Pilanci, K. N., Okutur, K. S., Yararbaş, K., ... & Ordu, Ç. (2023). Clinical and inflammation marker features of cancer patients with COVID-19: data of Istanbul, Turkey multicenter cancer patients (2020–2022). Current Medical Research and Opinion, 39(7), 987-996. - Ünal, Ç., Özmen, T., Ordu, Ç., Pilanci, K. N., İlgün, A. S., Gökmen, E., ... & Ozmen, V. (2023). Survival results according to Oncotype Dx recurrence score in patients with hormone receptor positive HER-2 negative early-stage breast cancer: first multicenter Oncotype Dx recurrence score survival data of Turkey. Frontiers in Oncology, 13, 1151733. - Özönder Ünal, I., Ünal, C., Duymaz, T., & Ordu, C. (2023). The relationship between psychological flexibility, self-compassion, and posttraumatic growth in cancer patients in the COVID-19 pandemic. Supportive Care in Cancer, 31(7), 428.